Rain Oncology Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rain Oncology Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2022.
  • Rain Oncology Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $1.04M, a 182% increase year-over-year.
  • Rain Oncology Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $4.35M, a 594% increase year-over-year.
  • Rain Oncology Inc. annual Nonoperating Income (Expense) for 2022 was $1.42M, a 1079% increase from 2021.
  • Rain Oncology Inc. annual Nonoperating Income (Expense) for 2021 was $120K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.42M +$1.3M +1079% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $120K +$2.25M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$2.13M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.